Latest Insider Transactions at Fennec Pharmaceuticals Inc. (FENC)
This section provides a real-time view of insider transactions for Fennec Pharmaceuticals Inc. (FENC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of FENNEC PHARMACEUTICALS INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of FENNEC PHARMACEUTICALS INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2025
|
Southpoint Capital Advisors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-26.7%
|
$7,000,000
$7.5 P/Share
|
|
Dec 05
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-11.43%
|
$70,000
$7.54 P/Share
|
|
Dec 01
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+5.62%
|
-
|
|
Dec 01
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,430
+1.37%
|
-
|
|
Nov 18
2025
|
Southpoint Capital Advisors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,341
-0.51%
|
$154,728
$8.79 P/Share
|
|
Nov 17
2025
|
Southpoint Capital Advisors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
85,918
-2.23%
|
$687,344
$8.79 P/Share
|
|
Nov 14
2025
|
Southpoint Capital Advisors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
160,100
-3.99%
|
$1,280,800
$8.0 P/Share
|
|
Nov 05
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-10.83%
|
$80,000
$8.1 P/Share
|
|
Oct 31
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,430
+1.38%
|
-
|
|
Oct 31
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+5.34%
|
-
|
|
Oct 10
2025
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
1,775
-3.02%
|
$15,975
$9.24 P/Share
|
|
Oct 10
2025
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
4,062
+6.46%
|
$4,062
$1.23 P/Share
|
|
Oct 09
2025
|
Southpoint Capital Advisors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,609
-0.51%
|
$185,481
$9.35 P/Share
|
|
Oct 08
2025
|
Southpoint Capital Advisors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,605
-0.48%
|
$176,445
$9.47 P/Share
|
|
Oct 08
2025
|
Rosty Raykov |
BUY
Exercise of conversion of derivative security
|
Direct |
4,609
+5.03%
|
$9,218
$2.45 P/Share
|
|
Oct 07
2025
|
Southpoint Capital Advisors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
26,900
-0.66%
|
$242,100
$9.59 P/Share
|
|
Oct 06
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-10.81%
|
$90,000
$9.78 P/Share
|
|
Sep 30
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,430
+1.4%
|
-
|
|
Sep 30
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+5.33%
|
-
|
|
Sep 05
2025
|
Rosty Raykov |
BUY
Exercise of conversion of derivative security
|
Direct |
36,207
+29.32%
|
$72,414
$2.45 P/Share
|
|
Sep 04
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-16.37%
|
$80,000
$8.92 P/Share
|
|
Aug 31
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+7.86%
|
-
|
|
Aug 31
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+1.42%
|
-
|
|
Aug 05
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-15.18%
|
$80,000
$8.09 P/Share
|
|
Jul 31
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+1.44%
|
-
|
|
Jul 31
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+7.33%
|
-
|
|
Jul 07
2025
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
1,119
-2.0%
|
$8,952
$8.71 P/Share
|
|
Jul 07
2025
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
2,127
+3.66%
|
$4,254
$2.35 P/Share
|
|
Jul 03
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-14.15%
|
$80,000
$8.61 P/Share
|
|
Jun 30
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+1.47%
|
-
|
|
Jun 30
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+6.86%
|
-
|
|
Jun 05
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-13.25%
|
$70,000
$7.78 P/Share
|
|
May 31
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+1.49%
|
-
|
|
May 31
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
5,208
+6.46%
|
-
|
|
May 22
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,220
+4.93%
|
$41,100
$5.1 P/Share
|
|
May 19
2025
|
Jeffrey S. Hackman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
13,965
+48.21%
|
$83,790
$6.99 P/Share
|
|
May 16
2025
|
Jeffrey S. Hackman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,035
+50.0%
|
$6,210
$6.75 P/Share
|
|
May 16
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
16,667
+9.98%
|
-
|
|
May 16
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
16,667
-19.17%
|
$100,002
$6.78 P/Share
|
|
May 16
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
33,334
+27.72%
|
-
|
|
May 05
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-15.73%
|
$60,000
$6.31 P/Share
|
|
Apr 30
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+3.68%
|
-
|
|
Apr 30
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.77%
|
-
|
|
Apr 11
2025
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
1,409
-2.55%
|
$5,636
$4.95 P/Share
|
|
Apr 11
2025
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
2,173
+3.79%
|
$4,346
$2.3 P/Share
|
|
Apr 04
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-14.05%
|
$50,000
$5.25 P/Share
|
|
Mar 31
2025
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+0.78%
|
-
|
|
Mar 31
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+3.3%
|
-
|
|
Mar 05
2025
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-12.7%
|
$60,000
$6.79 P/Share
|
|
Feb 28
2025
|
Rosty Raykov |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+3.0%
|
-
|